Head-to-head · WeighScore
Oak vs Care Bare Rx
The verdict
Oak takes it — 75.9/100 to 75/100, but only just.
Oak grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. The cheapest published prices on the board, sold as a package with no membership fee. Care Bare Rx is close behind and may still be the better fit — see the factor split below.
We may earn a commission if you start care through some of these links, at no extra cost to you. Affiliate partners are listed first — a capped 3-point edge in board order only. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Oak | Care Bare Rx |
|---|---|---|
| WeighScore | 75.9/100 | 75/100 |
| Grade | C | C |
| Scorecard rank | #40 | #41 |
| Semaglutide | From $119/mo | From $199/mo (shared weight-loss price) |
| Tirzepatide | From $185/mo | From $199/mo (shared weight-loss price) |
| Coverage | All 50 states | Multi-state |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Injection only | Yes |
Graded #40 · C
Strengths
- Lowest published prices here — semaglutide from $119/mo, tirzepatide from $185/mo
- One price across every dosage, so titrating up costs no more
- No membership or subscription fee, and free shipping
- All 50 states, offered in Spanish as well as English
Where it loses points
- Same-day approval with no video call means very little clinical contact before a prescription
- No published lab or monitoring programme
- Injection only, and no brand-name lane
- Sold as packages, so re-ordering is on you
Graded #41 · C
Strengths
- Oral tirzepatide as well as injectable — rare on this board
- Brand Ozempic (from $705/mo) and oral Rybelsus beside the compounded line
- LegitScript certified and HIPAA compliant
- One platform if you also want hair, TRT, sexual health or NAD+
Where it loses points
- The advertised "from $199/mo" is one figure shared across all weight-loss treatments — neither molecule priced separately
- Per-dose pricing is quiz-gated, so a titrated cost cannot be modelled beforehand
- No named clinicians, founding year or parent company disclosed
- Compounded medication is not FDA-approved the way brand Ozempic, Wegovy, or Zepbound are
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 43 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.